Ad blocking detected

Thank you for visiting We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). Private browsing Firefox users should be able to disable tracking protection while visiting our website. Visit Mozilla support for more information. If you do not believe you have any ad-blocking software on your browser, you may want to try another browser, computer or internet service provider. Alternatively, you may consider the following if you want an ad-free experience.

Canadian Insider Club
$299/ year*
Daily Morning INK newsletter
+3 months archive
Canadian Market INK weekly newsletter
+3 months archive
30 publication downloads per month from the PDF store
Top 20 Gold, Top 30 Energy, Top 40 Stock downloads from the PDF store
All benefits of basic registration
No 3rd party display ads

* Price is subject to applicable taxes.

Paid subscriptions and memberships are auto-renewing unless cancelled (easily done via the Account Settings Membership Status page after logging in). Once cancelled, a subscription or membership will terminate at the end of the current term.

Willow Biosciences Inc. (C:WLLW)

Business Focus: Biopharmaceuticals

Get the company report for the most recent outlook updated daily
Log in or join to add this stock to your watch list.

Insider Chart - Past 6 Months

Insider Filings

Latest 10 SEDI filings for WLLW within the last 6 months
See all filings within the past 6 months

Company News

Jul 22, 2019 08:30 ET
Synthetic Cannabinoids: The New Age of Medical Marijuana-- CFN Media
Seattle, Washington--(Newsfile Corp. - July 22, 2019) - CFN Media Group ("CFN Media"), the leading agency and financial media network dedicated to the North American cannabis industry, announces the publication of an article covering Willow Biosciences (CSE: WLLW) (OTC: CANSF) and the fascinating world of biosynthetically produced cannabinoids.
Read full article
Jul 11, 2019 17:16 ET
Willow Biosciences Comments on Share Price Activity
CALGARY, July 11, 2019 /CNW/ - Willow Biosciences Inc. ("Willow" or the "Company") (CSE: WLLW), at the request of IIROC on behalf of the Canadian Securities Exchange, announces that it is not aware of any material facts or changes in respect of the business of the Company which would result in a significant change in the trading price and volume of the common shares of the Company.
Read full article
See more news stories

Valuation Ratios

Price to Sales - TTM
Price to Book - most recent quarter
Price to Cash Flow per share - TTM
Price to Free Cash Flow per share - TTM
See all valuations

Short Report

DateNumber of Shares ShortedNet Change
Aug 15, 201936,852-20,638
Jul 31, 201957,490-24,263
Jul 15, 201981,753-147,357
See Short Report

Business Summary

Sector:  Healthcare Industry:  Pharmaceuticals

Willow Biosciences Inc., formerly Makena Resources Inc., is a Canada-based research and development company. The Company is focused on creating synthetic biology solution from gene discovery to cannabinoid commercialization.

See business summary

Comment On!

Upload limit is up to 1mb only
To post messages to your Socail Media account, you must first give authorization from the websites. Select the platform you wish to connect your account to (via Easy Blurb).


Search (past week) for $WLLW.CA

  • No tweets found